VIVS

VivoSim Labs, Inc. - Common Stock (VIVS)

About VivoSim Labs, Inc. - Common Stock (VIVS)

VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

Details

Daily high
$0.32
Daily low
$0.26
Price at open
$0.31
52 Week High
$5.30
52 Week Low
$0.26
Market cap
4.7M
Dividend yield
-
Volume
59,881
Avg. volume
10.5M
P/E ratio
-.07

VivoSim Labs, Inc. - Common Stock News

Details

Daily high
$0.32
Daily low
$0.26
Price at open
$0.31
52 Week High
$5.30
52 Week Low
$0.26
Market cap
4.7M
Dividend yield
-
Volume
59,881
Avg. volume
10.5M
P/E ratio
-.07